CD4+ CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas

被引：0

作者：

Katharina Baur

Andreas Buser

Lukas T. Jeker

Nina Khanna

Heinz Läubli

Dominik Heim

Jan C. Dirks

Corinne C. Widmer

Thomas Volken

Jakob R. Passweg

Andreas Holbro

机构：

[1] University Hospital Basel,Division of Hematology

[2] University Hospital Basel,Innovation Focus on Cell Therapies

[3] Blood Transfusion Service,Department of Biomedicine

[4] Swiss Red Cross,Transplantation Immunology & Nephrology

[5] University Hospital and University of Basel,Division of Infectious Diseases and Hospital Epidemiology

[6] University Hospital Basel,Department of Internal Medicine, Division of Oncology

[7] University and University Hospital of Basel,Diagnostic Hematology

[8] University Hospital Basel,Department of Health Institute for Public Health

[9] University Hospital,undefined

[10] ZHAW Zurich University of Applied Science,undefined

来源：

Bone Marrow Transplantation | 2023年 / 58卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1048 / 1050

页数：2

共 50 条

[21] CAR T-Cell Therapy in Large B-Cell Lymphoma
Quintas-Cardama, Alfonso
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (11): : 1065 - 1065
[22] CD22 CAR T-cell therapy: new hope for patients with large B-cell lymphoma
Schubert, Maria-Luisa
Dreger, Peter
LANCET, 2024, 404 (10450): : 314 - 315
[23] T-CELL RICH B-CELL LYMPHOMAS
JAFFE, ES
GONZALEZ, CL
MEDEIROS, LJ
RAFFELD, M
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1991, 15 (05) : 491 - 492
[24] Resistance of B-Cell Lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation
Laurent, Camille
Syrykh, Charlotte
Hamon, Maxime
Adelaide, Jose
Guille, Arnaud
Escudie, Frederic
Jalowicki, Gael
Fina, Frederic
Bardet, Alexandre
Mescam, Lenaig
Molina, Thierry J.
Dartigues, Peggy
Parrens, Marie
Sujobert, Pierre
Besson, Caroline
Birnbaum, Daniel
Xerri, Luc
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2022, 46 (06) : 742 - 753
[25] Response to Mosunetuzumab in Patients with B-Cell Lymphomas Relapsed or Refractory after CAR-T Cell Therapy Is Associated with Changes in Lymphocyte Counts
Chong, Elise A.
Penuel, Elicia
Bartlett, Nancy L.
Bosch, Francesc
Budde, L. Elizabeth
Fay, Keith
Flinn, Ian W.
Goy, Andre
Kumar, Anita
Lundberg, Rachel
Napier, Ellen B.
Nastoupil, Loretta J.
Shadman, Mazyar
Wei, Michael C.
Wu, Mei
Yin, Shen
Chong, Emeline R.
Schuster, Stephen J.
BLOOD, 2023, 142
[26] Monocytoid B-cell reaction associated with peripheral T-cell lymphomas
Plank, L
Hansmann, ML
Fischer, R
PATHOLOGY RESEARCH AND PRACTICE, 1995, 191 (11) : 1152 - 1158
[27] B-CELL LYMPHOMAS MORPHOLOGICALLY RESEMBLING T-CELL LYMPHOMAS
MIRCHANDANI, I
PALUTKE, M
TABACZKA, P
GOLDFARB, S
EISENBERG, L
PAK, MSY
CANCER, 1985, 56 (07) : 1578 - 1583
[28] Multicenter, randomized phase II study of epcoritamab for patients with large B-cell lymphomas achieving a partial response after CD19-directed CAR T-cell therapy (CAR-T).
Bock, Allison Marie
Raj, Sandeep
Giri, Sharmila
Leslie, Lori Ann
Patel, Dilan Anil
Iqbal, Madiha
Grover, Natalie Sophia
Hu, Boyu
Perales, Miguel-Angel
Nowakowski, Grzegorz S.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[29] Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma
Hashmi, Hamza
Mirza, Abu-Sayeef
Darwin, Alicia
Logothetis, Constantine
Garcia, Franco
Kommalapati, Anuhya
Mhaskar, Rahul S.
Bachmeier, Christina
Chavez, Julio C.
Shah, Bijal
Pinilla-Ibarz, Javier
Khimani, Farhad
Lazaryan, Aleksandr
Liu, Hien
Davila, Marco L.
Locke, Frederick L.
Nishihori, Taiga
Jain, Michael D.
BLOOD ADVANCES, 2020, 4 (17) : 4086 - 4090
[30] Targeting CD79b for Chimeric Antigen Receptor T-Cell Therapy of B-Cell Lymphomas
Shengnan Ding
Xia Mao
Yang Cao
Na Wang
Hao Xu
Jianfeng Zhou
Targeted Oncology, 2020, 15 : 365 - 375

← 1 2 3 4 5 →